These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25907296)

  • 1. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
    Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
    Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
    Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
    Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
    Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.
    Xu X; Chen H; Zhu X; Ma Y; Liu Q; Xue Y; Chu H; Wu W; Wang J; Zou H
    Clin Exp Immunol; 2013 Sep; 173(3):523-35. PubMed ID: 23682982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
    Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
    Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
    Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
    Lu WJ; Chua MS; So SK
    Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
    Zittermann SI; Capurro MI; Shi W; Filmus J
    Int J Cancer; 2010 Mar; 126(6):1291-301. PubMed ID: 19816934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
    Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
    Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
    Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
    Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
    Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP
    Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Nakajima Y; Inagaki Y; Kido J; Nagata T
    Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
    Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.